Dr. Marie Paule Richard, MD (CMO)

Position:

Chief Medical Officer (CMO)

Academic degrees:

• M.D., Human Biology in Clinical Immunology, in Clinical Pharmacology and Pharmacokinetics
• General Management (CEDEP-INSEAD)
• Postgraduate studies in Tropical Epidemiology, Vaccinology, Statistics, Medical Genetics

Professional experience:

• Hospital practitioner in congenital and acquired (HIV) immune deficiencies
• Investigator for clinical trials.

Industrial experience:

24 years experience in the clinical development of Anti-Infectives and Vaccines in the pharmaceutical industry and for biotechnology companies: 

• Medical Manager, Bristol-Myer Squibb until 1993 
• International Clinical Project Manager, Rhône D.P.C. Europe (joint-venture Rhône Poulenc Rorer - Dainippon) until 1996
• Associate Director, then Global Director,  RPR/Aventis Pharma until 2000
• Global Senior Director, Glaxo SmithKline until 2001
• Vice President Clinical Development France, Sanofi Pasteur until 2007
• Consultant Medical Advisor for several biotechnology companies in Switzerland and France until 2010
• Vice President Clinical Development and Operations, Pharmacovigilance and Medical Affairs, Crucell, 2010

FDA/EMEA/international development and/or regulatory submissions of Cefepime® , Azactam® , Zagam® , Synercid® , Augmentin XR® , Vaxigrip® yearly renewals, Intenza® and up to 13 other prophylactic and therapeutic vaccines.

Successful due diligences for a Capital Venture Fonds and for the Antifungal of a Swiss biotechnology company.

Memberships/ Supervisory Boards:

• French Societies of Microbiology (SFM), Immunology (SFI), Pharmaceutical Physicians (AMIPS), Pharmaceutical Companies (LEEM)
• EFPIA
• Industry Leaders   

Publications:

Author/co-author of more than 20 scientific publications and abstracts/posters.

Stipends/Awards:

Prize-winning Award in Medicine (Laureate) from the University of Medicine (Nancy, France).